Literature DB >> 22422936

Shedding light on melanocyte pathobiology in vivo.

M Raza Zaidi1, Edward C De Fabo, Frances P Noonan, Glenn Merlino.   

Abstract

Cutaneous malignant melanoma is rapidly increasing in the developed world and continues to be a challenge in the clinic. Although extensive epidemiologic evidence points to solar UV as the major risk factor for melanoma, there is a significant gap in our knowledge about how this most ubiquitous environmental carcinogen interacts with the largest organ of the mammalian body (skin) at the microenvironmental and molecular level. We review some recent advances that have started to close this gap. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422936      PMCID: PMC3319844          DOI: 10.1158/0008-5472.CAN-11-2586

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

Review 2.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

Review 3.  Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?

Authors:  Jörg Wischhusen; Anne Waschbisch; Heinz Wiendl
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

4.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

Review 5.  UV and pigmentation: molecular mechanisms and social controversies.

Authors:  T Thanh-Nga Tran; Joshua Schulman; David E Fisher
Journal:  Pigment Cell Melanoma Res       Date:  2008-10       Impact factor: 4.693

6.  Ultraviolet wavebands and melanoma initiation.

Authors:  Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2008-10       Impact factor: 4.693

7.  Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas.

Authors:  Yun Wang; John J Digiovanna; Jere B Stern; Thomas J Hornyak; Mark Raffeld; Sikandar G Khan; Kyu-Seon Oh; M Christine Hollander; Philip A Dennis; Kenneth H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-27       Impact factor: 11.205

8.  CTLA-4 control over Foxp3+ regulatory T cell function.

Authors:  Kajsa Wing; Yasushi Onishi; Paz Prieto-Martin; Tomoyuki Yamaguchi; Makoto Miyara; Zoltan Fehervari; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2008-10-10       Impact factor: 47.728

9.  Deficient inflammatory response to UV radiation in neonatal mice.

Authors:  Agnieszka Wolnicka-Glubisz; Jesse Damsker; Stephanie Constant; Stephanie Corn; Edward De Fabo; Frances Noonan
Journal:  J Leukoc Biol       Date:  2007-03-16       Impact factor: 4.962

Review 10.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.

Authors:  Darryl A Oble; Robert Loewe; Ping Yu; Martin C Mihm
Journal:  Cancer Immun       Date:  2009-04-02
View more
  10 in total

Review 1.  Molecular mechanisms of the preventable causes of cancer in the United States.

Authors:  Erica A Golemis; Paul Scheet; Tim N Beck; Eward M Scolnick; David J Hunter; Ernest Hawk; Nancy Hopkins
Journal:  Genes Dev       Date:  2018-06-26       Impact factor: 11.361

Review 2.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

3.  Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.

Authors:  Ke Yao; Hanyong Chen; Kangdong Liu; Alyssa Langfald; Ge Yang; Yi Zhang; Dong Hoon Yu; Myoung Ok Kim; Mee-Hyun Lee; Haitao Li; Ki Beom Bae; Hong-Gyum Kim; Wei-Ya Ma; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-03

4.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

Review 5.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

6.  While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2017-05-11

Review 7.  Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases.

Authors:  Abdul Q Khan; Sabah Akhtar; Kirti S Prabhu; Lubna Zarif; Rehan Khan; Majid Alam; Joerg Buddenkotte; Aamir Ahmad; Martin Steinhoff; Shahab Uddin
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 8.  UVA Radiation, DNA Damage, and Melanoma.

Authors:  Seung-Gi Jin; Francisco Padron; Gerd P Pfeifer
Journal:  ACS Omega       Date:  2022-09-08

9.  Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.

Authors:  Maria Wehbe; Saïdi M Soudja; Amandine Mas; Lionel Chasson; Rodolphe Guinamard; Céline Powis de Tenbossche; Grégory Verdeil; Benoît Van den Eynde; Anne-Marie Schmitt-Verhulst
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

10.  Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).

Authors:  Shirley Tong; Maris A Cinelli; Naglaa Salem El-Sayed; He Huang; Anika Patel; Richard B Silverman; Sun Yang
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.